Joint Research with Tokushima Univ.  to Be Presented at ERS 2025 (Pulmonary Fibrosis)

June 19, 2025



  • At the ERS (European Respiratory Society) Congress 2025,
    to be held from September 27 to October 1, 2025 in Amsterdam, the Netherlands,
    the research group led by Professor Yasuhiko Nishioka
    of the Department of Respiratory and Rheumatology, Tokushima University Graduate School of Biomedical Sciences,
    will present our joint research results on
    2ccPA (2-carba cyclic phosphatidic acid; synthetic compound, drug candidate)
    for pulmonary fibrosis.

    The poster presentation is scheduled for September 30,
    within the session titled
    “Translational science in interstitial lung disease 2.”

    【Presentation Title】
    The novel autotaxin inhibitor, 2-carba cyclic phosphatidic acid ameliorates bleomycin-induced lung fibrosis in mice.

    【External Link】
    ERS Congress 2025:
    https://www.ersnet.org/congress-and-events/congress/